In a paper setting out its negotiating terms, the government calls for a far reaching-science and innovation pact and says it will respect the remit of the European Court of Justice
The era of prescription digital health has dawned with approval of an app assessed to the same standard of clinical evidence as a conventional drug. Now pharma companies and digital therapy pioneers are forging development and marketing deals, while EU regulators and payers flounder
IMI is celebrating its 10th anniversary with a high-level event in Brussels on 27 June. Join us to meet IMI projects and explore their successes and the impact they are having on drug development.
The seal of excellence is as much a signifier of the EU’s R&D funding shortfall as it is of Europe’s high quality science. Now, the EU wants money from the cohesion programme to fill the funding gap and translate research to market
President Trump’s move to impose tariffs on steel and aluminum imports has fired the starting gun on an innovation war, in which the US aims to protect advanced technologies from Chinese incursions. Europe risks being caught in the cross fire
The largest piece of EU science infrastructure in Eastern Europe is also the first to be built – at a cost of €300M - with structural funds. Money was not an issue, but rules for constructing roads and railways don’t work for research facilities
Instant diagnosis of major diseases, the eradication of all road accidents, and the creation of 1 million new jobs are some of the benefits that will be generated by the Photonics sector by 2030 according to a new vision paper published by Photonics21.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.